-
- 岡本 美孝
- 千葉大学大学院医学研究院耳鼻咽喉科・頭頸部腫瘍学
書誌事項
- タイトル別名
-
- Adoptive Immunotherapy for Head and Neck Squamous Cell Cancer
- トウケイブ ヘンペイ ジョウヒ ガン ニ タイスル サイボウ メンエキ チリョウ
この論文をさがす
抄録
To improve the prognosis and QOL of patients with head and neck cancer, the development of new treatment strategies is of critical importance. We found that nasal submucosal administration of antigen presenting cells (APCs) is an effective and useful route for modalities affecting the immune system. Human Vα24 natural killer T (NKT) cells have a strong antitumor activity and are activated by a specific glycolipid antigen α-Galactosylceramide (α-GalCer). We carried out Phase-1 and Phase-1/2a study of nasal submucosal injection of α-GalCer-pulsed APCs and the intra-arterial infusion of activated NKT cells in unresectable or recurrent head and neck squamous cell cancer and showed the induction of significant anti-tumor immunity and some beneficial effects. The use of such therapeutic modalities may be helpful in the management of head and neck squamous cell cancer and need to be explored further. We summarize the present status of anti-cancer immunotherapy in the management of head and neck squamous cell cancer.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 101 (4), 247-253, 2008
耳鼻咽喉科臨床学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204264657536
-
- NII論文ID
- 10021294239
-
- NII書誌ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL書誌ID
- 9445423
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可